On 14th December St. Jude Medical, Inc. announced that has classified Riata and Riata ST defibrillation leads for class-I recall. U.S. Food and Drug Administration (FDA) has classified St. Jude’s voluntary medical device advisory letter to physicians from Nov. 28, 2011, which advised physicians to not use these leads as they are showing a higher rate of failure. The malfunctioning of either device or its leads causes critical complications and therefore the recall has been classified as Class-I.

Previous ArticleRiata Defibrillator And Cardiac Tamponade Lawsuits Next ArticleSanofi In Trouble As Multaq Said To Cause Liver Damages
Verdicts and Settlements
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers